Inhalable Drugs Market Size, Share, Future Prospects and Forecast 2020-2026
The global inhalable drug market is anticipated to grow at a CAGR of 3.7% during the forecast period (2020-2026). The rising geriatric population that is more prone to respiratory diseases, augmentation in the predominance of respiratory and non-respiratory diseases, along with the rapidly changing lifestyles of the people creates demand for inhalable drugs and hence drives the growth of the market. The trend of smoking, drinking alcohol, and ill eating activity are increasing among the people which is a major risk for the development of various pulmonary diseases. As per the COPD Foundation of the US, the top three causes of COPD are environmental factors, smoking, and genetic factor. COPD is mostly occurred in people of age above 40 and having a history of smoking.

Request a free sample of our report on Inhalable Drugs Market: https://www.omrglobal.com/request-sample/inhalable-drugs-market

Non-respiratory diseases such as diabetes, Parkinson’s diseases, among many others are also becoming increasingly prevalent among the geriatric population. Owing to this, manufacturers are focused on the development of inhalable drugs for adult people as it is hard to swallow for them. For instance, in December 2018, the US FDA approved the INBRIJA drug, manufactured by Acorda Therapeutics as an inhalable prescription medicine for adults suffering from Parkinson’s disease. Thus, such aforementioned factors are likely to positively influence the growth of the market over the forecast period.

A full report of Inhalable Drugs Market Is available at https://www.omrglobal.com/industry-reports/inhalable-drugs-market

Global Inhalable Drugs Market Segmentation

By Applications

Respiratory Diseases

Non-Respiratory Diseases

By Route of Administration

Nasal

Mouth

Regional Analysis

North America

United States

Canada

Europe

UK

Germany

Italy

Spain

France

Rest of Europe

Asia-Pacific

China

India

Japan

Rest of Asia-Pacific

Rest of the World

Company Profiles

AptarGroup, Inc.

AstraZeneca Plc

Bausch Health Companies Inc.

Boehringer Ingelheim International GmbH

Cipla Ltd.

F. Hoffmann-La Roche Ltd.

GlaxoSmithKline Plc

Johnson & Johnson Services Inc.

Medisol Lifescience Pvt. Ltd.

Merck & Co., Inc.

For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/inhalable-drugs-market

About Us:

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting, and other research-based services.

For More Information, Visit https://www.omrglobal.com/

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: [email protected]

Contact no: +91 780-304-0404